Board of Scientific Counselors, National Center for Injury Prevention and Control, 26546 [2023-09066]
Download as PDF
26546
Federal Register / Vol. 88, No. 83 / Monday, May 1, 2023 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors,
National Center for Injury Prevention
and Control
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of closed meeting.
AGENCY:
In accordance with regulatory
provisions, the Centers for Disease
Control and Prevention (CDC)
announces the following meeting for the
Board of Scientific Counselors, National
Center for Injury Prevention and Control
(BSC, NCIPC or Board). This meeting is
closed to the public.
DATES: The meeting will be held on June
8, 2023, from 1 p.m. to 3:30 p.m., EDT
(CLOSED).
ADDRESSES: Webinar, Atlanta, Georgia.
FOR FURTHER INFORMATION CONTACT:
Christopher R. Harper, Ph.D.,
Designated Federal Officer, National
Center for Injury Prevention and
Control, Centers for Disease Control and
Prevention, 4770 Buford Highway NE,
Mailstop S–1069, Atlanta, Georgia
30341. Telephone: (404) 718–8330;
Email: ncipcbsc@cdc.gov.
SUPPLEMENTARY INFORMATION: The
meeting referenced above will be closed
to the public in accordance with
provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director,
Strategic Business Initiatives Unit,
Office of the Chief Operating Officer,
CDC, pursuant to 5 U.S.C. 1009 (Pub. L.
92–463, as amended).
Purpose: The Board of Scientific
Counselors, National Center for Injury
Prevention and Control (BSC, NCIPC or
Board) will: (1) conduct, encourage,
cooperate with, and assist other
appropriate public health authorities,
scientific institutions, and scientists in
the conduct of research, investigations,
experiments, demonstrations, and
studies relating to the causes and
strategies related to the prevention of
injury and violence; (2) assist States and
other entities in preventing intentional
and unintentional injuries, and to
promote health and well-being; and (3)
make recommendations of grants and
cooperative agreements for research and
prevention activities related to injury
and violence. The BSC, NCIPC makes
recommendations regarding policies,
strategies, objectives, and priorities and
reviews progress toward injury and
violence prevention. The Board also
lotter on DSK11XQN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
17:10 Apr 28, 2023
Jkt 259001
provides advice on the appropriate
balance of intramural and extramural
research and provides guidance on the
needs, structure, progress, and
performance of intramural programs.
The Board also provides guidance on
extramural scientific program matters.
The Board provides second-level
scientific and programmatic review for
applications for research grants,
cooperative agreements, and training
grants related to injury and violence
prevention, and recommends approval
of projects that merit further
consideration for funding support. The
Board also recommends areas of
research to be supported by contracts
and cooperative agreements and
provides concept reviews of program
proposals and announcements.
Matters To Be Considered: The closed
meeting will focus on the Secondary
Peer Review of extramural research
grant applications received in response
to five (5) Notices of Funding
Opportunity: RFA–CE–23–002—‘‘Grants
to Support New Investigators in
Conducting Research Related to
Understanding Polydrug Use Risk and
Protective Factors’’; RFA–CE–23–003—
‘‘Grants to Support New Investigators in
Conducting Research Related to
Preventing Interpersonal Violence
Impacting Children and Youth’’; RFA–
CE–23–004—‘‘Research Grants for
Preventing Violence and Violence
Related Injury (R01)’’; RFA–CE–23–
005—‘‘Research Grants to Inform
Firearm-Related Violence and Injury
Prevention Strategies (R01)’’; and RFA–
CE–23–006—‘‘Research Grants to
Rigorously Evaluate Innovative and
Promising Strategies to Prevent FirearmRelated Violence and Injuries (R01).’’
Agenda items are subject to change as
priorities dictate.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2023–09066 Filed 4–28–23; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–23–23EH; Docket No. CDC–2023–
0030]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled Public Health Emergency
Management Capacity Assessment Tool
(PHEM Tool). The Center for Disease
Control and Prevention’s (CDC) Global
Emergency Management Capacity
Development (GEMCD) team will use
the PHEM Tool to assess the public
health emergency management (PHEM)
program and Public Health Emergency
Operations Center (PHEOC) capacity of
Global Health Security Agenda (GHSA)
countries.
DATES: CDC must receive written
comments on or before June 30, 2023.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2023–
0030 by either of the following methods:
• Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
www.regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(www.regulations.gov) or by U.S. mail to
the address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
SUMMARY:
E:\FR\FM\01MYN1.SGM
01MYN1
Agencies
[Federal Register Volume 88, Number 83 (Monday, May 1, 2023)]
[Notices]
[Page 26546]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-09066]
[[Page 26546]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Board of Scientific Counselors, National Center for Injury
Prevention and Control
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of closed meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with regulatory provisions, the Centers for
Disease Control and Prevention (CDC) announces the following meeting
for the Board of Scientific Counselors, National Center for Injury
Prevention and Control (BSC, NCIPC or Board). This meeting is closed to
the public.
DATES: The meeting will be held on June 8, 2023, from 1 p.m. to 3:30
p.m., EDT (CLOSED).
ADDRESSES: Webinar, Atlanta, Georgia.
FOR FURTHER INFORMATION CONTACT: Christopher R. Harper, Ph.D.,
Designated Federal Officer, National Center for Injury Prevention and
Control, Centers for Disease Control and Prevention, 4770 Buford
Highway NE, Mailstop S-1069, Atlanta, Georgia 30341. Telephone: (404)
718-8330; Email: [email protected].
SUPPLEMENTARY INFORMATION: The meeting referenced above will be closed
to the public in accordance with provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to 5 U.S.C. 1009 (Pub. L. 92-463, as
amended).
Purpose: The Board of Scientific Counselors, National Center for
Injury Prevention and Control (BSC, NCIPC or Board) will: (1) conduct,
encourage, cooperate with, and assist other appropriate public health
authorities, scientific institutions, and scientists in the conduct of
research, investigations, experiments, demonstrations, and studies
relating to the causes and strategies related to the prevention of
injury and violence; (2) assist States and other entities in preventing
intentional and unintentional injuries, and to promote health and well-
being; and (3) make recommendations of grants and cooperative
agreements for research and prevention activities related to injury and
violence. The BSC, NCIPC makes recommendations regarding policies,
strategies, objectives, and priorities and reviews progress toward
injury and violence prevention. The Board also provides advice on the
appropriate balance of intramural and extramural research and provides
guidance on the needs, structure, progress, and performance of
intramural programs. The Board also provides guidance on extramural
scientific program matters. The Board provides second-level scientific
and programmatic review for applications for research grants,
cooperative agreements, and training grants related to injury and
violence prevention, and recommends approval of projects that merit
further consideration for funding support. The Board also recommends
areas of research to be supported by contracts and cooperative
agreements and provides concept reviews of program proposals and
announcements.
Matters To Be Considered: The closed meeting will focus on the
Secondary Peer Review of extramural research grant applications
received in response to five (5) Notices of Funding Opportunity: RFA-
CE-23-002--``Grants to Support New Investigators in Conducting Research
Related to Understanding Polydrug Use Risk and Protective Factors'';
RFA-CE-23-003--``Grants to Support New Investigators in Conducting
Research Related to Preventing Interpersonal Violence Impacting
Children and Youth''; RFA-CE-23-004--``Research Grants for Preventing
Violence and Violence Related Injury (R01)''; RFA-CE-23-005--``Research
Grants to Inform Firearm-Related Violence and Injury Prevention
Strategies (R01)''; and RFA-CE-23-006--``Research Grants to Rigorously
Evaluate Innovative and Promising Strategies to Prevent Firearm-Related
Violence and Injuries (R01).'' Agenda items are subject to change as
priorities dictate.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-09066 Filed 4-28-23; 8:45 am]
BILLING CODE 4163-18-P